Literature DB >> 19606280

The Role of Glial Cells in Drug Abuse.

Jose Javier Miguel-Hidalgo1.   

Abstract

Neuronal dysfunction in the prefrontal cortex, limbic structures, nucleus accumbens and ventral tegmental area is considered to underlie the general physiopathological mechanisms for substance use disorders. Glutamatergic, dopaminergic and opioidoergic neuronal mechanisms in those brain areas have been targeted in the development of pharmacotherapies for drug abuse and dependence. However, despite the pivotal role of neurons in the mechanisms of addiction, these cells are not the only cell type in charge of sustaining and regulating neurotransmission. Glial cells, particularly astrocytes, play essential roles in the regulation of glutamatergic neurotransmission, neurotransmitter metabolism, and supply of energy substrates for synaptic transmission. In addition, astrocytes are markedly affected by exposure to ethanol and other substances of abuse. These features of astrocytes suggest that alterations in the function of astrocytes and other glial cells in reward circuits may contribute to drug addiction. Recent research has shown that the control of glutamate uptake and the release of neurotrophic factors by astrocytes influences behaviors of addiction and may play modulatory roles in psychostimulant, opiate, and alcohol abuse. Less is known about the contributions of microglia and oligodendrocytes to drug abuse, although, given the ability of these cells to produce growth factors and cytokines in response to alterations in synaptic transmission, further research should better define their role in drug addiction. The available knowledge on the involvement of glial cells in addictive behaviors suggests that regulation of glutamate transport and neurotrophins may constitute new avenues for the treatment of drug addiction.

Entities:  

Year:  2009        PMID: 19606280      PMCID: PMC2709875          DOI: 10.2174/1874473710902010076

Source DB:  PubMed          Journal:  Curr Drug Abuse Rev        ISSN: 1874-4737


  108 in total

Review 1.  Astrocyte control of synaptic transmission and neurovascular coupling.

Authors:  Philip G Haydon; Giorgio Carmignoto
Journal:  Physiol Rev       Date:  2006-07       Impact factor: 37.312

2.  The involvement of glial cells in the development of morphine tolerance.

Authors:  P Song; Z Q Zhao
Journal:  Neurosci Res       Date:  2001-03       Impact factor: 3.304

3.  An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-alpha protects against methamphetamine-induced rewarding effects and sensitization.

Authors:  Minae Niwa; Atsumi Nitta; Yuichiro Yamada; Akira Nakajima; Kuniaki Saito; Mitsuru Seishima; Liya Shen; Yukihiro Noda; Shoei Furukawa; Toshitaka Nabeshima
Journal:  Biol Psychiatry       Date:  2006-10-13       Impact factor: 13.382

Review 4.  Aquaporins in brain: distribution, physiology, and pathophysiology.

Authors:  Jérôme Badaut; François Lasbennes; Pierre J Magistretti; Luca Regli
Journal:  J Cereb Blood Flow Metab       Date:  2002-04       Impact factor: 6.200

5.  Ethanol exposure decreases glutamate uptake in the nucleus accumbens.

Authors:  Roberto I Melendez; Megan P Hicks; Stephanie S Cagle; Peter W Kalivas
Journal:  Alcohol Clin Exp Res       Date:  2005-03       Impact factor: 3.455

6.  Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

Authors:  J D Rothstein; M Dykes-Hoberg; C A Pardo; L A Bristol; L Jin; R W Kuncl; Y Kanai; M A Hediger; Y Wang; J P Schielke; D F Welty
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

7.  Glutamatergic neurotransmission and protein kinase C play a role in neuron-glia communication during the development of methamphetamine-induced psychological dependence.

Authors:  Mayumi Miyatake; Minoru Narita; Masahiro Shibasaki; Atsushi Nakamura; Tsutomu Suzuki
Journal:  Eur J Neurosci       Date:  2005-09       Impact factor: 3.386

8.  Protein phosphorylation cascades associated with methamphetamine-induced glial activation.

Authors:  M A Hebert; J P O'Callaghan
Journal:  Ann N Y Acad Sci       Date:  2000-09       Impact factor: 5.691

9.  Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area.

Authors:  D Beitner-Johnson; X Guitart; E J Nestler
Journal:  J Neurochem       Date:  1993-11       Impact factor: 5.372

10.  Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers.

Authors:  G A Ricaurte; L S Seiden; C R Schuster
Journal:  Brain Res       Date:  1984-06-15       Impact factor: 3.252

View more
  37 in total

1.  ENT1 regulates ethanol-sensitive EAAT2 expression and function in astrocytes.

Authors:  Jinhua Wu; Moonnoh R Lee; Sun Choi; Taehyun Kim; Doo-Sup Choi
Journal:  Alcohol Clin Exp Res       Date:  2010-04-05       Impact factor: 3.455

2.  The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice.

Authors:  Sarah E Snider; Sarah A Vunck; Edwin J C G van den Oord; Daniel E Adkins; Joseph L McClay; Patrick M Beardsley
Journal:  Eur J Pharmacol       Date:  2012-01-28       Impact factor: 4.432

Review 3.  Translational potential of astrocytes in brain disorders.

Authors:  Alexei Verkhratsky; Luca Steardo; Vladimir Parpura; Vedrana Montana
Journal:  Prog Neurobiol       Date:  2015-09-16       Impact factor: 11.685

4.  Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders.

Authors:  Alexei Verkhratsky; Vladimir Parpura
Journal:  Neurobiol Dis       Date:  2015-04-03       Impact factor: 5.996

5.  Stratification of astrocytes in healthy and diseased brain.

Authors:  Alexei Verkhratsky; Robert Zorec; Vladimir Parpura
Journal:  Brain Pathol       Date:  2017-09       Impact factor: 6.508

6.  Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes.

Authors:  Irma E Cisneros; Anuja Ghorpade
Journal:  Neuropharmacology       Date:  2014-06-17       Impact factor: 5.250

Review 7.  Glial modulators as potential treatments of psychostimulant abuse.

Authors:  Patrick M Beardsley; Kurt F Hauser
Journal:  Adv Pharmacol       Date:  2014

Review 8.  Metaplasticity at the addicted tetrapartite synapse: A common denominator of drug induced adaptations and potential treatment target for addiction.

Authors:  Daniela Neuhofer; Peter Kalivas
Journal:  Neurobiol Learn Mem       Date:  2018-02-09       Impact factor: 2.877

9.  Striatal adenosine signaling regulates EAAT2 and astrocytic AQP4 expression and alcohol drinking in mice.

Authors:  Moonnoh R Lee; Christina L Ruby; David J Hinton; Sun Choi; Chelsea A Adams; Na Young Kang; Doo-Sup Choi
Journal:  Neuropsychopharmacology       Date:  2012-10-03       Impact factor: 7.853

10.  Dorsal hippocampal neural immune signaling regulates heroin-conditioned immunomodulation but not heroin-conditioned place preference.

Authors:  Jacqueline E Paniccia; Christina L Lebonville; Meghan E Jones; Shveta V Parekh; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2018-07-31       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.